ARTICLE
ejd.2010.1251
Auteur(s) : Romina RODRÍGUEZ-LOJO rodriguezlojo@hotmail.com,
Beatriz FERNÁNDEZ-JORGE, Ana DE ANDRÉS, Carmen PEÑA, Jesús
GARCÍA-SILVA
Servicio de Dermatología, CHU A Coruña, Sir John Moore, s/n.
15001, A Coruña, Spain
Surgical management of cutaneous squamous cell carcinomas (CSCC)
in patients with severe generalised recessive dystrophic
epidermolysis bullosa (SGRDEB) is hindered by the fragility of
their skin. We present a patient with SGRDEB who underwent excision
of multiple CSCC, with wound closure by secondary intention,
obtaining good results without significant associated
complications.
A 49-year-old woman diagnosed with SGRDEB had been seen in our
department since 1998. She had significant skin fragility,
extensive areas of scarring and associated systemic complications
(chronic renal failure, chronic anaemia, secondary
hyperparathyroidism and protein-calorie malnutrition). In 1999 she
underwent surgery in the Plastic Surgery department for CSCC in her
left leg, and reconstruction with a split-skin graft. This had a
poor outcome, with necrosis and total graft loss.
The patient continued to develop many CSCC while being seen in
our department over an 11-year follow-up period. It was decided to
resect the tumours and to proceed with wound closure by secondary
intention (figure 1A),
excising a total of 31 squamous cell carcinomas. All tumours were
located on the lower limbs except one on the right forearm and
another on her scalp. Tumour size ranged from 1.3 to 7.5 cm.
From 1 to 6 carcinomas were excised in each surgical procedure.
The interventions were performed under local anaesthesia as an
outpatient procedure. After excising the tumour and a margin of
3-5 mm, haemostasis was performed carefully, leaving the wound
to close by secondary intention. The wound was covered with an
extra thin hydrocolloid dressing (Urgotul®) or silicone
mesh netting (Mepitel®) with povidone-iodine gel
(Betadine®). After surgery, the wound was cleaned every
other day with saline, applying Betadine® solution,
silver sulfadiazine or mupirocin ointment, covering the surgical
wound with a hydrocolloid dressing (Urgotul®) and
bandage. The patient was seen once a week for the wound dressing
and to observe progress, and visits were later spaced out. In the
first week after surgery abundant granulation tissue was observed,
with complete wound closure within 4-6 weeks (figure
1B).
CSCC are a frequent cause of death in patients with SGRDEB
[1, 2]. It has been suggested that possible factors
contributing to this aggressiveness are the structural alteration
of the basement membrane, which facilitates tumour invasion, and
also the reduction in circulating NK cells [2]. Surgical treatment
is complex. Different techniques, such as flaps, grafts and
artificial grafts have been described [1-6]. We opted for wound
closure by secondary intention, which has a series of benefits:
- – Surgical procedures were performed under local anaesthesia,
avoiding intubation complications due to fragile mucosa. Also,
general anaesthesia is not risk-free because of the multiple
associated systemic diseases.
- – Hospitalisation was not required.
- – It is possible to excise multiple tumours in a single
intervention, thus avoiding delay in surgical treatment.
- – There is less manipulation of surrounding skin.
- – The technique is appropriate in patients with extensive skin
scarring, which prevents mobilising skin easily for skin flaps and
limits the areas of skin that are suitable for use as donor skin
grafts.
The main disadvantage of wound closure by secondary intention is
the delay in wound reepithelialisation, which is furthered by the
malnutrition, requiring careful wound dressing for several weeks.
However these patients are used to meticulous wound dressing
because traumatic skin injuries are commonplace. We also believe
that the total healing time is acceptable, and that good
nutritional control is important to help enhance the wound healing
process.
In our experience, wound closure by secondary intention is a
useful and safe option in the surgical treatment of cutaneous
squamous cell carcinomas in patients with epidermolysis
bullosa.
Disclosure
Acknowledgements: We would like to thank
Ma Angeles Fernández Entralgo for her
fundamental work and collaboration in patient follow-up and care.
Financial support: none. Conflict of interest: none.
References
1 M Yamada, N Hatta, K Sogo, K Komura, Y Hamaguchi, K. Takehara
Management of squamous cell carcinoma in a patient with
recessive-type epidermolysis bullosa dystrophica Dermatol
Surg 2004; 30: 1424-1429.
2 SD Buonocore, S. Ariyan Cadaveric allograft for wound closure
after resection of squamous cell carcinoma in patients with
recessive dystrophic epidermolysis bullosa: a report of 32
resections and repairs in 2 patients Ann Plast Surg 2009;
63: 297-299.
3 EB Mohr, JA Lohmeyer, NC Mikhaimer, P Maillsquänder, T
Schwarz, A. Hauschild Multiple squamous cell carcinomas in
junctional epidermolysis bullosa: a surgical challenge Dermatol
Surg 2008; 34: 1131-1136.
4 G Dagregorio, G. Guillet Artificial skin as a valuable adjunct
to surgical treatment of a large squamous cell carcinoma in a
patient with epidermolysis bullosa Dermatol Surg 2005; 31:
474-476.
5 DP Fivenson, L Scherschun, M Choucair, D Kukuruga, J Young, T.
Shwayder Graftskin therapy in epidermolysis bullosa J Am Acad
Dermatol 2003; 48: 886-892.
6 L. Bruckner-Tuderman Epidermolysis bullosa Eur J
Dermatol 2008; 18: 214-216.
|